We are live on ! Find out more
MA

MYDA Advisors Portfolio holdings

AUM $608M
1-Year Est. Return 77.08%
This Fund
S&P 500
This Quarter Est. Return
-0.11%
1 Year Est. Return
+77.08%
3 Year Est. Return
+189.24%
5 Year Est. Return
+248.06%
10 Year Est. Return
AUM
$357M
AUM Growth
-$43.8M
Cap. Flow
-$31.5M
Cap. Flow %
-8.82%
Top 10 Hldgs %
26.98%
Holding
360
New
86
Increased
29
Reduced
54
Closed
99

Top Sells

Rank Stock Value
1
TASK icon
TaskUs
TASK
+$8.12M
2
T icon
AT&T
T
+$6.09M
3
SONY icon
Sony
SONY
+$5.84M
4
ZIP icon
ZipRecruiter
ZIP
+$3.81M
5
EQC
Equity Commonwealth
EQC
+$3.79M

Sector Composition

Rank Sector Weight
1 Financials 24.45%
2 Healthcare 9.51%
3 Communication Services 8.7%
4 Industrials 7.33%
5 Technology 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZON.U
176
DELISTED
Horizon Acquisition Corporation II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
HZON.U
$402K 0.11%
40,000
NUVB icon
177
Nuvation Bio
NUVB
$2.24B
$398K 0.11%
40,000
-6,000
-13% -$54.4K
LUXAW
178
DELISTED
Lux Health Tech Acquisition Corp. Warrants
LUXAW
$392K 0.11%
340,509
ZNTEU
179
DELISTED
Zanite Acquisition Corp. Unit
ZNTEU
$379K 0.11%
36,000
FMAC.WS
180
DELISTED
FirstMark Horizon Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one shar
FMAC.WS
$378K 0.11%
300,000
ARYD
181
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$371K 0.1%
36,935
VYGG.U
182
DELISTED
Vy Global Growth Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant to acquire one Class A Ordinary Share
VYGG.U
$362K 0.1%
36,000
RSVR icon
183
Reservoir Media
RSVR
$700M
$351K 0.1%
38,528
-21,472
-36% -$189K
GOAC
184
DELISTED
GO Acquisition Corp. Class A Common Stock
GOAC
$346K 0.1%
35,287
MYPS icon
185
PLAYSTUDIOS Inc
MYPS
$79.3M
$337K 0.09%
74,000
+30,060
+68% +$169K
LFTR
186
DELISTED
Lefteris Acquisition Corp. Class A Common Stock
LFTR
$333K 0.09%
34,000
UNG icon
187
United States Natural Gas Fund
UNG
$470M
$323K 0.09%
+4,000
New +$241K
OMEG
188
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$312K 0.09%
32,000
AUPH icon
189
Aurinia Pharmaceuticals
AUPH
$1.97B
$310K 0.09%
+14,000
New +$222K
TFFP
190
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$309K 0.09%
+1,600
New +$340K
RNW icon
191
ReNew
RNW
$2.24B
$306K 0.09%
+30,000
New +$300K
NVVEW
192
DELISTED
Newborn Acquisition Corp Warrant
NVVEW
$300K 0.08%
220,697
-12,000
-5% -$19K
BOWX
193
DELISTED
BowX Acquisition Corp. Class A Common Stock
BOWX
$300K 0.08%
30,000
-23,829
-44% -$245K
FPAC
194
DELISTED
Far Peak Acquisition Corporation
FPAC
$299K 0.08%
30,000
-40,000
-57% -$398K
MTCH icon
195
Match Group
MTCH
$8.84B
$298K 0.08%
1,899
REVHU
196
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
$296K 0.08%
30,000
CRVS icon
197
Corvus Pharmaceuticals
CRVS
$1.1B
$290K 0.08%
+60,000
New +$178K
SEGG
198
Sports Entertainment Gaming Global Corp
SEGG
$14.4M
$278K 0.08%
120
-30
-20% -$69K
DNA.WS
199
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$272K 0.08%
+80,356
New +$286K
LEGOW
200
DELISTED
Legato Merger Corp. Warrant
LEGOW
$270K 0.08%
+107,986
New +$251K

Similar funds

MYDA Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, MYDA Advisors held 360 positions worth $357M, down 11% from $401M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

MYDA Advisors withdrew a net $31.5M in Q3 2021, closing 99 positions and reducing 54 holdings. Its most notable exit was TaskUs, an estimated $8.12M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, MYDA Advisors opened a new position in Stevanato worth $3.29M.

  • MYDA Advisors's largest Q3 2021 buy was Stevanato: 130,000 shares worth $3.29M.
  • MYDA Advisors added most to Regeneron Pharmaceuticals in Q3 2021, an estimated $4.16M increase.
  • MYDA Advisors's biggest Q3 2021 reduction was AT&T, cutting an estimated $6.09M.
  • MYDA Advisors fully exited TaskUs in Q3 2021, selling an estimated $8.12M.
  • MYDA Advisors's ten largest holdings make up 27% of its $357M portfolio in Q3 2021.
  • MYDA Advisors opened 86 new positions and closed 99 in Q3 2021.
  • MYDA Advisors's portfolio value fell 11% quarter-over-quarter to $357M.

Based on MYDA Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.